BRIEF published on 09/02/2026 at 12:35, 20 days 23 hours ago Immunic organise une journée virtuelle de recherche et développement sur la sclérose en plaques Biotechnologie Vidofludimus Calcium Immunitaire SEP Récurrente Événement R&D
BRIEF published on 09/02/2026 at 12:35, 20 days 23 hours ago Immunic to Host Virtual R&D Day on Multiple Sclerosis Biotechnology Immunic Vidofludimus Calcium Relapsing MS R&D Event
PRESS RELEASE published on 09/02/2026 at 12:30, 21 days ago Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 Immunic, Inc. to host a virtual R&D day on relapsing multiple sclerosis on September 9, 2026, discussing its Phase 3 trial asset, vidofludimus calcium, to address neurologic diseases Immunic Inc. Phase 3 Trial Vidofludimus Calcium Relapsing Multiple Sclerosis Virtual R&D Day
BRIEF published on 09/01/2026 at 12:35, 21 days 23 hours ago Immunic nomme Chitrang Davé au poste de directrice des données et du numérique Sclérose En Plaques Vidofludimus Calcium Immunitaire Chitrang Davé Données Et Numérique
BRIEF published on 09/01/2026 at 12:35, 21 days 23 hours ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Multiple Sclerosis Immunic Vidofludimus Calcium Chitrang Davé Data And Digital
PRESS RELEASE published on 09/01/2026 at 12:30, 22 days ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Immunic appoints Chitrang Davé as Chief Data and Digital Officer, reinforcing commitment to building a robust data ecosystem for potential NDA submission and commercialization Chief Data Officer Immunic Digital Officer NDA Submission Chitrang Davé
BRIEF published on 08/11/2026 at 12:35, 1 month 11 days ago Immunic, Inc. publie ses résultats financiers et ses mises à jour pour le deuxième trimestre 2026 Vidofludimus Calcium Investissements En Biotechnologie Essais Cliniques Sur La Sclérose En Plaques Nominations De Dirigeants Immunic Financials
BRIEF published on 08/11/2026 at 12:35, 1 month 11 days ago Immunic, Inc. Reports Q2 2026 Financial Results and Updates Vidofludimus Calcium Leadership Appointments Multiple Sclerosis Trials Biotech Investments Immunic Financials
PRESS RELEASE published on 08/11/2026 at 12:30, 1 month 12 days ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2026 financial results and corporate update, with leadership team expansions and Phase 3 trials progress for vidofludimus calcium in MS Financial Results Corporate Update Immunic Inc. Vidofludimus Calcium Q2 2026
BRIEF published on 08/10/2026 at 22:10, 1 month 12 days ago Elena Ridloff rejoint le conseil d'administration d'Immunic en tant que directrice stratégique Vidofludimus Calcium Leadership En Biotechnologie Conseil D'immunisation Elena Ridloff Phase 3 ENSURE
Published on 09/23/2026 at 09:05, 3 hours 27 minutes ago Algo Grande Copper Confirms 68.43 Metres of Copper-Silver-Gold Mineralization Across Two Zones in Hole AG-CG-PH2-002, Including a New Zone of 38.20 Metres at 1.0% CuEq
Published on 09/23/2026 at 08:00, 4 hours 32 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/23/2026 at 07:30, 5 hours 2 minutes ago Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
Published on 09/23/2026 at 04:45, 7 hours 47 minutes ago SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach
Published on 09/23/2026 at 02:45, 9 hours 47 minutes ago Presentation to Beaver Creek Precious Metals Summit
Published on 09/23/2026 at 12:25, 7 minutes ago SANY Renewable Energy Reports Over 300% Overseas Revenue Growth at WindEnergy Hamburg 2026
Published on 09/23/2026 at 12:05, 27 minutes ago Constellation Cold Logistics ("Constellation") announced today the appointment of Abhy Maharaj as Chief Executive Officer
Published on 09/23/2026 at 12:00, 32 minutes ago Shanghai Electric Presents Three Energy Transition Solutions at Enlit Asia 2026
Published on 09/23/2026 at 11:46, 46 minutes ago Turkiye Garanti Bankasi A.S.: Intermediary Institution Warrants Issuance Application
Published on 09/23/2026 at 11:44, 48 minutes ago Seahawk Investments Expands Alternative Investment Platform with Launch of Maritime Private Credit Fund
Published on 09/23/2026 at 08:00, 4 hours 32 minutes ago Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Published on 09/22/2026 at 18:00, 18 hours 32 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 18 hours 32 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 18 hours 47 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
